Australia markets closed

Heron Therapeutics, Inc. (HRTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.2300-0.0700 (-5.38%)
At close: 04:00PM EST
1.2300 0.00 (0.00%)
Pre-market: 09:00AM EST
Currency in USD
Earnings estimateCurrent qtr. (Dec 2023)Next qtr. (Mar 2024)Current year (2023)Next year (2024)
No. of analysts4134
Avg. Estimate-0.15-0.08-0.96-0.38
Low estimate-0.19-0.08-0.99-0.61
High estimate-0.13-0.08-0.93-0.18
Year ago EPS-0.17-0.27-1.67-0.96
Revenue estimateCurrent qtr. (Dec 2023)Next qtr. (Mar 2024)Current year (2023)Next year (2024)
No. of analysts3133
Avg. Estimate30.94M32.88M123.74M140.18M
Low estimate30.21M32.88M123.02M135.25M
High estimate31.7M32.88M124.5M145.1M
Year ago sales30.03M29.61M107.67M123.74M
Sales growth (year/est)3.00%11.00%14.90%13.30%
Earnings history30/12/202230/03/202329/06/202329/09/2023
Est. EPS-0.28-0.2-0.23-0.29
Actual EPS-0.17-0.27-0.35-0.17
Difference0.11-0.07-0.120.12
Surprise %39.30%-35.00%-52.20%41.40%
EPS trendCurrent qtr. (Dec 2023)Next qtr. (Mar 2024)Current year (2023)Next year (2024)
Current estimate-0.15-0.08-0.96-0.38
7 days ago-0.15-0.08-0.96-0.38
30 days ago-0.28-0.22-1.21-0.63
60 days ago-0.28-0.22-1.21-0.63
90 days ago-0.28-0.22-1.21-0.63
EPS revisionsCurrent qtr. (Dec 2023)Next qtr. (Mar 2024)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days3142
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesHRTXIndustrySector(s)S&P 500
Current qtr.11.80%N/AN/AN/A
Next qtr.70.40%N/AN/AN/A
Current year42.50%N/AN/AN/A
Next year60.40%N/AN/AN/A
Next 5 years (per annum)47.50%N/AN/AN/A
Past 5 years (per annum)-43.36%N/AN/AN/A